/
Login
Analysis Scores
Damodaran ?
38/100
Dalio Risk ?
68/100
Piotroski ?
-
Bilanço dosyası bulunamadı
Graham ?
-
Bilanço dosyası bulunamadı
Active Metric?
4/4
Confidence?
75%
Valuation
Potential?
-28.4%
ROIC ?
11.8%
DCF Value ?
4.58
Debt Cycle?
Early Expansion
Data
Data ?
2729
2015-11-18 → 2026-08-31
Risk Analysis (VaR)
Yüksek
252 days
Annual Volatility ?
%43.2
VaR 95% ?
%4.29
daily max loss
VaR 99% ?
%6.14
daily max loss
CVaR 95% ?
%4.53
expected loss (tail)
Max Drawdown ?
%21.5
27.02.2026 → 26.06.2026
Skewness ?
1.40
Parametrik%4.29
Historik%3.67
Cornish-Fisher%2.78
Return Distribution
Fundamental & Technical Analysis
TRAMA-99 Trend — Strong Uptrend
Price (11.51), TRAMA-99 line's %25.1 above. Strong uptrend continues. Technical momentum positive.
Price:: 11.51
TRAMA: 9.2012
Difference: %+25.1
Profitability
No balance sheet data
Valuation
P/E Ratio
16.2x
Sector: 15.9x
F/K 16.2x — sector median's (15.9x) %2 above. Slight premium.
P/B Ratio
10.93x
Sector: 2.80x
PD/DD 10.93x — sector median's %290 above. Expensive book value.
EV/EBITDA
8.2x
Sector: 5.6x
EV/EBITDA 8.2x — sector median's (5.6x) %45 above. EBITDA’ya göre pahalı.
Indebtedness
Net Debt / EBITDA
0.4x
Net Borç/EBITDA 0.4x — very low debt burden. Company can repay debt quickly.
Debt / Equity
0.57x
Borç/Özkaynak 0.57x — moderate financial leverage.
Interest Coverage
41.0x
Interest coverage 41.0x — very wide margin for paying interest expenses.
Growth
No balance sheet data
Score Explanations
Lothien Robustness
43/100
Moderate robustness (43/100). Valuation and risk criteria give mixed signals. Detailed review recommended.
Moderate
Potential
-28.4%
Minus %28.4 expected value (8.24) vs current price comparison. 4/4 valuation models give 'BUY' signal. Model confidence %75.
Components: PE target: 11.30 | P/B target: 3.45 | EV/EBITDA target: 7.92 | DCF target: 4.58
Damodaran Valuation
38/100
Low Damodaran score (38/100). ROIC (%11.8) below cost of capital. DCF analysis does not support current price.
Weak
Dalio Risk Analysis
68/100
Moderate debt risk (68/100). Interest coverage ratio 41.0x — strong. Borç/EBITDA 0.4x — in healthy range.
Leverage: 90/100 | Debt Service: 100/100 | Quality: 42/100
ROIC – Sermaye Getirisi
%11.8
ROIC (%11.8) cost of capitaln (12.7%) below → destroying value.
WACC: %12.7
DCF Discounted Cash Flow
4.58
DCF (4.58) current price %60.2 below — cash flows do not support current price.
Current price: 11.51
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
—
Bilanço dosyası bulunamadı
Graham Intrinsic Value
—
Bilanço dosyası bulunamadı
⚖️ Sector Comparison
P/E Ratio
16.2x
vs 15.9x
Sector mediannın %2 above — expensive
P/B Ratio
10.93x
vs 2.80x
Compared to sector %290 more expensive (by book value)
EV/EBITDA
8.2x
vs 5.6x
Compared to sector %45 higher EV/EBITDA
ROIC vs WACC
%11.8
vs %12.7 WACC
ROIC 0.9 baz puan cost of capitaln altında
Charts
Indicators
BB deviation
?
RSI thresholds
?
PWH — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.